Evidence map›Paper›PMID 35530795›Full record

ArticleRSC advances2019

Amino-acid functionalized porous silicon nanoparticles for the delivery of pDNA.

Arnaud Chaix, Eduardo Cueto-Diaz, Anthony Delalande, Nikola Knezevic, Patrick Midoux, Jean-Olivier Durand, Chantal Pichon, Frederique Cunin

Abstract read
In one paragraph

Article in RSC advances, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. NonviralACS nano · 2023
    Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Arnaud ChaixInstitut Charles Gerhardt Montpellier, Charles Gerhardt Montpellier, Université de Montpellier UMR 5253 CNRS-ENSCM-UM2-UM1, 2 Place Eugène Bataillon 34095 Montpellier Cedex 05 France frederique.cunin@enscm.fr.
Eduardo Cueto-DiazInstitut Charles Gerhardt Montpellier, Charles Gerhardt Montpellier, Université de Montpellier UMR 5253 CNRS-ENSCM-UM2-UM1, 2 Place Eugène Bataillon 34095 Montpellier Cedex 05 France frederique.cunin@enscm.fr.
Anthony DelalandeCentre de Biophysique Moléculaire in Orleans (CBM) UPR4301 France.
Nikola KnezevicBiosense Institute, University of Novi Sad Dr Zorana Djindjica 1 21000 Novi Sad Serbia.ORCID https://orcid.org/0000-0002-1563-7763
Patrick MidouxCentre de Biophysique Moléculaire in Orleans (CBM) UPR4301 France.
Jean-Olivier DurandInstitut Charles Gerhardt Montpellier, Charles Gerhardt Montpellier, Université de Montpellier UMR 5253 CNRS-ENSCM-UM2-UM1, 2 Place Eugène Bataillon 34095 Montpellier Cedex 05 France frederique.cunin@enscm.fr.ORCID https://orcid.org/0000-0003-4606-2576
Chantal PichonCentre de Biophysique Moléculaire in Orleans (CBM) UPR4301 France.
Frederique CuninInstitut Charles Gerhardt Montpellier, Charles Gerhardt Montpellier, Université de Montpellier UMR 5253 CNRS-ENSCM-UM2-UM1, 2 Place Eugène Bataillon 34095 Montpellier Cedex 05 France frederique.cunin@enscm.fr.ORCID https://orcid.org/0000-0003-4624-8418

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Porous silicon nanoparticles as a novel platform in gene therapy, have shown to be an efficient vehicle for the delivery of nucleic acids in cells. For the first time, a family of porous silicon nanoparticles has been produced featuring an amino-acid functionalized cationic external surface aiming at pDNA complexation. The amino acid-based pDNA nanocarriers, displaying an average diameter of 295 nm, succeeded in transfection of HEK293 cells with an efficiency 300 times superior to "bare" porous silicon nanoparticles.

Identifiers

PMID35530795
PMCPMC9072902

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.